sorafenib has been researched along with deoxyelephantopin in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (deoxyelephantopin) | Trials (deoxyelephantopin) | Recent Studies (post-2010) (deoxyelephantopin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 39 | 0 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, M; Chen, JJ; Liu, Q; Song, SJ; Yan, QL; Yao, GD | 1 |
1 other study(ies) available for sorafenib and deoxyelephantopin
| Article | Year |
|---|---|
Deoxyelephantopin, a germacrane-type sesquiterpene lactone from Elephantopus scaber, induces mitochondrial apoptosis of hepatocarcinoma cells by targeting Hsp90α in vitro and in vivo.
Topics: Apoptosis; Asteraceae; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Lactones; Liver Neoplasms; Mitochondria; Molecular Docking Simulation; Sesquiterpenes; Sesquiterpenes, Germacrane; Sorafenib | 2023 |